CURE vs SPXL

ACURE

BSPXL

Measures won2–4SPXL wins · of 6 · 5Y

$10,000 · 5Y$21,895SPXL · CURE $14,551

Lowest cost0.94%CURE · $94 on $10k

Most income0.76%CURE · $76 on $10k

Smallest drop−26.8%SPXL · worst fall in 1Y

Held in common2.2%CURE and SPXL

CURE

SPXL

Direxion Daily Healthcare Bull 3X ETF · $200MDirexion Daily S&P 500 Bull 3X Shares · $6.5B

+31.0%3 years · per year$22,495 · $40,354+59.2%

+7.8%5 years · per year$14,551 · $21,895+17.0%

0.94%Expense ratio$94 · $95 on $10k · lower wins0.95%

0.76%12-mo yield$76 · $54 on $10k0.54%

−31.1%Worst dropSmaller wins−26.8%

48.0%VolatilityLower wins38.3%

2–4SPXL wins

$10,000 · 5 yearsOne scale

Shared top holdingsCURE · SPXL

3.5%LLY0.4%

2.0%JNJ0.2%

1.6%ABBV0.2%

1.1%MRK0.1%

Held in common2.2%

End-of-day Nov 3, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

Both

5Y2 funds

#			Trend
1	BSPXL	Direxion Daily S&P 500 Bull 3X SharesRead Desk		0.95%	0.54%	+0.9%	+22.5%	+20.6%	+59.2%	+17.0%	−26.8%	$6.5B
2	ACURE	Direxion Daily Healthcare Bull 3X ETFRead Desk		0.94%	0.76%	−0.7%	+49.8%	+82.5%	+31.0%	+7.8%	−31.1%	$200M

End-of-day Nov 3, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Both

5Y2 funds

#			Trend
1	BSPXL	Direxion Daily S&P 500 Bull 3X SharesRead Desk		0.95%	0.54%	+0.9%	+22.5%	+20.6%	+59.2%	+17.0%	−26.8%	$6.5B
2	ACURE	Direxion Daily Healthcare Bull 3X ETFRead Desk		0.94%	0.76%	−0.7%	+49.8%	+82.5%	+31.0%	+7.8%	−31.1%	$200M

End-of-day Nov 3, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

CURE vs SPXL

CURE

Direxion Daily Healthcare Bull 3X

$14,551

SPXL

Direxion Daily S&P 500 Bull 3X Shares

$21,895

MeasureCURESPXL

Fee0.94%0.95%

Cost on $10k a year$94$95

Yield0.76%0.54%

5 years, per year+7.8%+17.0%

3 years, per year+31.0%+59.2%

Worst drop · 1Y−31.1%−26.8%

Volatility · 1Y48.0%38.3%

4–2measures won
SPXL first

2.2%

holdings shared

Nov 3, 2026 · $10,000 five years ago, dividends reinvested

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+7.5%

JEPIJ.P. Morgan

+7.0%

+7.5%Year to date+7.0%

12.3%Yield8.0%

$41.8BAssets$46.0B

2–0JEPQ wins

End-of-day Nov 3, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026

Overlap: CURE, SPXL

Today

2.2%most shared, CURE and SPXL

CURESPXL

CURE—2.2%

SPXL2.2%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Income After Fees on $10,000

−$18most kept, CURE

CURE$76 − $94 = −$18

SPXL$54 − $95 = −$41

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee